PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: American Pharmacists Association

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

APhA to FDA - Pharmacist Intervention Essential to Potential Revisions to Drug Paradigm - The American Pharmacists Association (APhA) presented testimony to the Food and Drug Association at the public hearing Using Innovative Technologies and other Conditions of Safe Use to Expand Which Drug Products Can Be Considered Nonprescription
APhA to FDA - Pharmacist Intervention Essential to Potential Revisions to Drug Paradigm

 

NewswireToday - /newswire/ - Washington, DC, United States, 2012/03/22 - The American Pharmacists Association (APhA) presented testimony to the Food and Drug Association at the public hearing Using Innovative Technologies and other Conditions of Safe Use to Expand Which Drug Products Can Be Considered Nonprescription.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

APhA today presented testimony to the Food and Drug Association (FDA) at the public hearing Using Innovative Technologies and other Conditions of Safe Use to Expand Which Drug Products Can Be Considered Nonprescription. At this hearing, the FDA is receiving input as it considers ways to make the distinction between prescription and nonprescription drugs less rigid; increasing patients access to needed medications under “conditions of safe use.” An example of a safe-use condition would be requiring an interaction with a pharmacist before the purchase of the medicine.

APhA presented testimony regarding the impact of this potential drug paradigm on pharmacists, patient access to pharmacists and the many opportunities pharmacists have to speak with patients with chronic conditions - treated and untreated - helping to channel those patients back into the health care system. APhA’s comments were presented by Thomas E. Menighan, BSPharm, MBA, ScD, FAPhA, APhA Executive Vice President and CEO.

APhA’s comments were based upon the following:

• Support for the concept of “conditions of safe use” for certain medications, which could include a consultation with a pharmacist.
• The opportunity to expand patient access, improve public health and provide another avenue to bring people who may have poorly treated chronic conditions back into the health care system.
• The opportunity to further communicate and collaborate with physicians and other providers.
• The success of pharmacist-administered immunizations and other patient care programs on improving public health. And,
• A recognition that there are several key focus areas to be resolved as the potential drug paradigm concept evolves.

Menighan commented,“While many details of this potential drug paradigm need to be worked out through future collaborations, none of them are significant enough to stop this important initiative from being enacted. America's pharmacists view this proposal as ‘Yes... if, ’ rather than ‘No... but.’ We look forward to working with FDA and other healthcare providers and stakeholders to answer the ‘if’ questions and make this concept a reality for the benefit of patients and the healthcare system.”

APhA’s complete testimony to the FDA can be found in the APhA Newsroom at pharmacist.com/newsroom.

About the American Pharmacists Association

The American Pharmacists Association (aphanet.org | pharmacist.com), founded in 1852 as the American Pharmaceutical Association, is a 501 ©(6) organization, representing more than 62,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession. APhA, dedicated to helping all pharmacists improve medication use and advance patient care, is the first-established and largest association of pharmacists in the United States.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: American Pharmacists Association

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


APhA to FDA - Pharmacist Intervention Essential to Potential Revisions to Drug Paradigm

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Michelle Fritts - APhAnet.org 
202-429-7558 mfritts[.]aphanet.org
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any American Pharmacists Association securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From American Pharmacists Association / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution
PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)